Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) Cash & Equivalents (2009 - 2026)

Updated

Immucell (ICCC) reported Cash & Equivalents of $7.91 million for Q3 2026, up 103.7% from $3.89 million a year earlier but down 10.7% from the prior quarter.

Analysis

Immucell (ICCC) Cash & Equivalents (2009 - 2026) Analysis & Trends

At the end of FY2025, Immucell posted Cash & Equivalents of $3.81 million, up 1.3% from FY2024.

  • Cash & Equivalents has a five-year compound annual growth rate of -11.3% (FY2020 to FY2025).
  • By year, Cash & Equivalents came in at $3.76 million in FY2024 (+284.0%), $978,741 in FY2023 (-83.1%), $5.79 million in FY2022 (-43.1%) and $10.19 million in FY2021 (+46.6%).
  • Five-year quarterly Cash & Equivalents spans a low of $960,347 in Q1 2024 and a high of $11.82 million in Q1 2022.
  • Year over year, Cash & Equivalents has now increased in each of the last nine quarters, with growth averaging 152.3% over the last eight quarters.
  • The high point for year-over-year Cash & Equivalents in five years was Q1 2025 (growth of 378.9%); the low point was Q2 2023 (a decline of 86.8%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $8.86 million (Q2 2026), $6.81 million (Q1 2026) and $3.81 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 16.91 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 10.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 400.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 7.94 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.82 Bn
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn 7.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 7.91 Mn
Jun 30, 2026 8.86 Mn
Mar 31, 2026 6.81 Mn
Dec 31, 2025 3.81 Mn
Sep 30, 2025 3.89 Mn
Jun 30, 2025 6.00 Mn
Mar 31, 2025 4.60 Mn
Dec 31, 2024 3.76 Mn
Sep 30, 2024 3.81 Mn
Jun 30, 2024 1.32 Mn
Mar 31, 2024 960,347.00
Dec 31, 2023 978,741.00
Sep 30, 2023 1.99 Mn
Jun 30, 2023 1.45 Mn
Mar 31, 2023 3.10 Mn
Dec 31, 2022 5.79 Mn
Sep 30, 2022 8.83 Mn
Jun 30, 2022 11.04 Mn
Mar 31, 2022 11.82 Mn
Dec 31, 2021 10.19 Mn
API Access

Immucell Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ICCC&period=max&api_key=YOUR_API_KEY